Nitric oxide regulation of CD55 and infection

一氧化氮对 CD55 和感染的调节

• 批准号: 8206846
• 负责人: CHANDRASEKHAR YALLAMPALLI
• 金额: $ 29.78万
• 依托单位: UNIVERSITY OF TEXAS MED BR GALVESTON
• 依托单位国家: 美国
• 财政年份: 2009
• 资助国家: 美国
• 起止时间: 2009-01-15 至 2013-12-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8206846
• 关键词: 3' Untranslated Regions; ANXA2 gene; Actins; Affect; Antiphospholipid Antibodies; Antiphospholipid Syndrome; Autologous; Bacteremia; Binding; Binding Sites; Biological Assay; Biological Availability; Blood Vessels; CD55 Antigens; CREB1 gene; Cell Line; Cell membrane; Cells; Ceramides; Cholesterol; Complement; Cyclic GMP; Cytoskeleton; DNA; Dactinomycin; Data; Disease; Dissociation; Dose; Down-Regulation; Endometrial; Endometrium; Epithelial Cells; Escherichia coli; Generations; Genetic Transcription; Human; Hydrolysis; Immune Tolerance; Implant; In Vitro; Infection; Inositol; Lateral; Lipids; Maternal Mortality; Mediating; Membrane; Membrane Microdomains; Messenger RNA; Metabolism; Modeling; Mutation; Names; Nitric Oxide; Nitric Oxide Donors; Nitric Oxide Synthase; Nuclear; Pathology; Pathway interactions; Patient observation; Phase; Phosphatidylinositols; Phosphotransferases; Play; Pre-Eclampsia; Pregnancy; Pregnancy loss; Premature Labor; Process; Production; Proteins; Publishing; Rat Cell Line; Rattus; Recurrence; Regulation; Reporter; Reporting; Role; Running; SP1 gene; Severities; Signal Pathway; Site; Sphingolipids; Sphingomyelins; Spontaneous abortion; Testing; Time; Tissues; Transcript; Transcription Factor AP-1; Transcription Factor AP-2 Alpha; Transfection; Up-Regulation; Uterus; caveolin 1; endometriosis; failure Implantation; fimbria; genetic regulatory protein; implantation; in vivo; inhibitor/antagonist; insight; mRNA Stability; pregnant; promoter; receptor; reproductive; transcription factor

PROJECT SUMMARY/ABSTRACT Nitric oxide (NO) and its reactive derivatives are widely known for regulating vascular tone. We have demonstrated that NO is a modulator of uterine infections due to Escherichia coli expressing Dr fimbriae (Dr+). E. coli through its Dr+ binds to decay-accelerating factor (CD55), a complement regulatory protein that protects cells from autologous complement-mediated damage. Elevated NO significantly decreased CD55 protein and mRNA in endometrial Ishikawa cells in a time and dose-dependent manner and consequently reduced bacterial invasion. We, therefore, hypothesize that NO inhibits CD55 expression and cellular distribution through direct actions at transcriptional level (Aim 1), indirectly through the modulation of sphingolipid metabolism and, thus altering P13K/Akt path-way (Aim 2) or locally at the membrane through altering the components of lipid rafts and their distribution (Aim 3). Further, NO modulates CD55 expression in rat uterus similar to the cell lines. These hypotheses will be tested in three specific aims. AIM 1. We will investigate the effect of NO on the transcription of CD55 DNA and on the stability of CD55 mRNA. 1.1. We will determine, by site directed mutations, the role of CREB, AP1, AP2, and SP1 binding sites at -74 to -43 region of CD55 promoter in the NO modulated transcription of CD55. 1.2. We will examine the effect of NO on CD55 mRNA stability by using actinomycin D assay. AIM 2. We will determine the involvement of sphingolipid metabolism and PI3K/Akt pathway signaling in NO-induced downregulation of CD55 expression. We will assess if NO 2.1. inhibits generation of ceramide in endometrial cells through decreasing hydrolysis of sphingomyelin, 2.2. alters intracellular distribution of ceramiide. 2.3. causes activation of PI3K/Akt pathway in down-regulating CD55 expression. AIM 3. We will examine the local effects of NO on the interaction of CD55 molecules with the components of lipid rafts in the membrane and their distribution. We will determine if NO 3.1. increases distance between lipid raft-associated molecules: GPI anchored CD55 and caveolin-1 and increase CD55 lateral mobility in the plasma membrane, 3.2. will alter dissociation of CD55 molecule from annexin II and actin cytoskeleton. AIM 4. We will demonstrate the effects of NO manipulations in vivo and ex-vivo on CD55 expression in the rat uterus, and assess the mechanisms of action. 4.1. We will determine the effects of in vivo manipulation of NO and its effects on the CD55 expression, PI3K/Akt pathway activation and ceramide levels in the uterus of rats. 4.2. We will investigate the in vitro effects of NO modifiers on CD55 expression in the rat uterus, and the involvement of PI3K/Akt pathway and ceramide in this process. 4.3. We will investigate the effects of NO modifiers on CD55 expression in human endometriosis and the involvement of PI3K/Akt pathway and ceramide in this process. These studies will provide mechanistic insights into the NO-induced down-regulation of CD55 expression and implications for implantation failure, pregnancy loss and severity of infection.

项目总结/文摘